BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Acrux Limited Announces Successful AXIRON Phase III Trial Results; Trial Met Primary Endpoint

  September 29, 2009

   · 

  7 min read
• Drug Development

  Boehringer Ingelheim Corporation’s Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin

  September 29, 2009

   · 

  4 min read
• Pharm Country

  Girl Dies After Receiving GlaxoSmithKline (JOBS) Cervical Cancer Vaccine; Link Between Death and Drug Not Yet Established

  September 29, 2009

   · 

  1 min read
• BioForest

  Philips Issues Worldwide Recall of Select HeartStart FR2+ Automated External Defibrillators

  September 29, 2009

   · 

  2 min read
• Business

  Kyorin Pharmaceutical Co., Ltd. and Eisai Company, Ltd. Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries

  September 29, 2009

   · 

  1 min read
• Drug Development

  Keryx Biopharmaceuticals: Updated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Carcinoma Reported at the Eighth International Kidney Cancer Symposium

  September 29, 2009

   · 

  6 min read
• Pharm Country

  Inspirion Delivery Technologies Announces Completion of Successful Pre-IND Meeting With The FDA On Abuse Deterrent Oxycodone ER Product

  September 29, 2009

   · 

  2 min read
• Grifols to Issue $600 Million in US Bonds

  September 29, 2009

   · 

  1 min read
• Deals

  Zhangjiang Hi-Tech Park Buys Stake in Buchang Pharma

  September 29, 2009

   · 

  1 min read
• Business

  Advanced Biological Laboratories SA (ABL) and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections

  September 29, 2009

   · 

  1 min read